Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/kyverna-therapeutics-provides-business-update-and-reports-full-year-2023-financial-results-302100073.html
https://www.prnewswire.com/news-releases/kyverna-therapeutics-and-stanford-university-agree-to-evaluate-kyv-101-in-patients-with-non-relapsing-and-progressive-forms-of-multiple-sclerosis-302083613.html
https://www.prnewswire.com/news-releases/kyverna-therapeutics-announces-closing-of-initial-public-offering-and-full-exercise-of-underwriters-option-to-purchase-additional-shares-302059964.html
https://www.fiercebiotech.com/biotech/kyverna-ceo-fresh-319m-ipo-says-were-next-phase-medicine
https://www.fiercebiotech.com/biotech/kyverna-overshoots-even-its-raised-ipo-expectations-bringing-319m-oversized-offering
https://www.prnewswire.com/news-releases/kyverna-therapeutics-announces-pricing-of-upsized-initial-public-offering-302056924.html
https://www.fiercebiotech.com/biotech/kyverna-ups-ipo-roughly-300-million-after-seeing-peers-land-upsized-raises
https://endpts.com/kyverna-seeks-182m-ipo-as-biotech-runs-multiple-autoimmune-car-t-trials/
https://www.fiercebiotech.com/biotech/kyverna-sets-ipo-range-eyeing-180m-haul-fund-broad-autoimmune-car-t-clinical-trial-program
https://endpts.com/kyverna-says-car-t-manufacturing-times-can-be-cut-through-blood-collection-efficiencies/